Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Bicycle Therapeutics (BCYC)

Bicycle Therapeutics PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCYC
DateTimeSourceHeadlineSymbolCompany
13/01/202521:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCYCBicycle Therapeutics PLC
13/01/202512:00Business WireBicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and MilestonesNASDAQ:BCYCBicycle Therapeutics PLC
09/01/202512:00Business WireBicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:BCYCBicycle Therapeutics PLC
07/01/202500:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
07/01/202500:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
07/01/202500:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
07/01/202500:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
07/01/202500:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
07/01/202500:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
07/01/202500:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
07/01/202500:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
07/01/202500:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
07/01/202500:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
06/01/202517:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
03/01/202521:05Business WireBicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BCYCBicycle Therapeutics PLC
02/01/202521:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
02/01/202521:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
02/01/202521:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
02/01/202521:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
02/01/202521:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
02/01/202521:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
19/12/202420:47Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BCYCBicycle Therapeutics PLC
13/12/202414:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCYCBicycle Therapeutics PLC
12/12/202423:30Business WireBicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene AmplificationNASDAQ:BCYCBicycle Therapeutics PLC
10/12/202412:00Business WireBicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology ExpertsNASDAQ:BCYCBicycle Therapeutics PLC
02/12/202421:05Business WireBicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BCYCBicycle Therapeutics PLC
25/11/202422:30Business WireBicycle Therapeutics to Present Data for Zelenectide Pevedotin at 2024 San Antonio Breast Cancer Symposium and Provide Program UpdateNASDAQ:BCYCBicycle Therapeutics PLC
14/11/202421:32Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BCYCBicycle Therapeutics PLC
14/11/202400:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
12/11/202414:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BCYCBicycle Therapeutics PLC
 Showing the most relevant articles for your search:NASDAQ:BCYC